Idiopathic nephrotic syndrome, IgA nephropathy, membranous nephropathy, focal segmental glomerulosclerosis, lupus nephritis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The study will include patients diagnosed with idiopathic nephrotic syndrome or other acquired kidney diseases who have stored serum samples, as well as patients or healthy volunteers who provide written informed consent to participate in the prospective cohort study.
Exclusion criteria
Exclusion criteria: Participants who do not provide consent for participation in the study, or who have evidence of infection such as fever, will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum anti-Crb2 antibody titers in patients with idiopathic nephrotic syndrome at onset and relapse | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Correlation between anti-Crb2 antibody titers and proteinuria 2. Association between anti-Crb2 antibody titers and disease activity 3. Association between serum anti-nephrin antibody titers, serum anti-sialic acid antibody titers, circulating chemokine levels, and serum anti-Crb2 antibody titers | — |
Countries
Japan
Contacts
Kyorin University School of Medicine Department of Pediatrics